Susquehanna International Group’s China Pharma Holdings CPHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,092
Closed -$2.71K 12113
2024
Q2
$2.71K Buy
+1,092
New +$3.35K ﹤0.01% 11842
2022
Q1
Sell
-46
Closed -$11K 13089
2021
Q4
$11K Buy
+46
New +$12.6K ﹤0.01% 12918
2021
Q1
Sell
-28
Closed -$6K 12297
2020
Q4
$6K Buy
+28
New +$6.02K ﹤0.01% 10927
2019
Q1
Sell
-199
Closed -$26K 8933
2018
Q4
$26K Sell
199
-8
-4% -$1.16K ﹤0.01% 8636
2018
Q3
$21K Buy
207
+157
+314% +$18.4K ﹤0.01% 8991
2018
Q2
$5K Buy
50
+13
+35% +$1.75K ﹤0.01% 9479
2018
Q1
$6K Buy
+37
New +$6.61K ﹤0.01% 9193
2017
Q3
Sell
-51
Closed -$6K 8890
2017
Q2
$6K Buy
51
+28
+122% +$3.17K ﹤0.01% 9089
2017
Q1
$3K Buy
+23
New +$2.92K ﹤0.01% 8802
2016
Q4
Sell
-66
Closed -$7K 9619
2016
Q3
$7K Buy
66
+26
+65% +$3.33K ﹤0.01% 8297
2016
Q2
$5K Buy
+40
New +$4.49K ﹤0.01% 8441
2015
Q2
Sell
-21
Closed -$4K 10125
2015
Q1
$4K Buy
+21
New +$3.62K ﹤0.01% 9330

Other funds holding CPHI

Susquehanna International Group's CPHI Position: Q3 2024 in Review

Susquehanna International Group sold out of China Pharma Holdings (CPHI) in Q3 2024, closing a stake of 1,092 shares — an estimated $2.71K sold.

Susquehanna International Group first reported a position in CPHI in Q1 2015 and held it in 12 quarters. The position peaked at $26K in Q4 2018. 4 funds tracked by Wall St. Rank hold CPHI as of Q3 2024.

  • Susquehanna International Group reported no remaining China Pharma Holdings position as of Q3 2024 after selling out during the quarter.
  • Susquehanna International Group sold 1,092 China Pharma Holdings shares in Q3 2024, an estimated $2.71K.
  • Susquehanna International Group first reported a position in China Pharma Holdings in Q1 2015 and held it in 12 quarters.
  • Susquehanna International Group's China Pharma Holdings position peaked at $26K in Q4 2018.
  • 4 funds tracked by Wall St. Rank held China Pharma Holdings as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.